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Summary
Objective: Our goal was to test the hypothesis that speciﬁc integrin receptors regulate chondrocyte biosynthetic response to dynamic com-
pression at early times in 3D gel culture, during initial evolution of the pericellular matrix, but prior to signiﬁcant accumulation of further-
removed matrix. The study was motivated by increased use of dynamic loading, in vitro, for early stimulation of tissue engineered cartilage,
and the need to understand the effects of loading, in vivo, at early times after implantation of constructs.
Methods: Bovine articular chondrocytes were seeded in 2% agarose gels (15 106 cells/mL) and incubated for 18 h with and without the pres-
ence of speciﬁc integrin blockers (small-molecule peptidomimetics, function-blocking antibodies, and RGD-containing disintegrins). Samples
were then subjected to a 24-h dynamic compression regime found previously to stimulate chondrocyte biosynthesis in 3D gel as well as
cartilage explant culture (1 Hz, 2.5% dynamic strain amplitude, 7% static offset strain). At the end of loading, proteoglycan (PG) synthesis
(35S-sulfate incorporation), protein synthesis (3H-proline incorporation), DNA content (Hoechst dye 33258) and total glycosaminoglycan
(GAG) content (dimethyl methylene blue (DMMB) dye binding) were assessed.
Results: Consistent with previous studies, dynamic compression increased PG synthesis and total GAG accumulation compared to free-swell-
ing controls. Blocking avb3 abolished this response, independent of effects on controls, while blocking b1 abolished the relative changes in
synthesis when changes in free-swelling synthesis rates were observed.
Conclusions: This study suggests that both avb3 and b1 play a role in pathways that regulate stimulation of PG synthesis and accumulation by
dynamic compression, but through distinct complementary mechanisms.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Mechanotransduction.Introduction
In vivo, articular cartilage experiences a combination of
compressive, tensile, and shear forces, both dynamic and
static in nature1e3. These mechanical forces can induce
a variety of macroscopic signals including changes in intra-
tissue pH and osmotic pressure, hydrostatic pressure gradi-
ents, ﬂuid ﬂow, streaming potentials and current, and
mechanical deformation4e6, which are sensed by chondro-
cytes and can regulate cell behavior. In vivo, static immobi-
lization or reduced joint-loading leads to a loss of
glycosaminoglycan (GAG) content and decreased proteo-
glycan (PG) synthesis, which can be partially rescued by re-
mobilization7,8. In vitro, radially unconﬁned dynamic
compression at frequencies greater than 0.001 Hz has
been shown to increase chondrocyte biosynthesis of PG
and protein in both explant and 3D agarose gel culture mod-
els9e12, while static compressive loading can lead to de-
creases in biosynthesis13e16. In vitro, static and dynamic*Address correspondence and reprint requests to: Alan J.
Grodzinsky, MIT, NE47-377, 77 Massachusetts Avenue,
Cambridge, MA 02139, United States. Tel: 1-(617)-253-4969;
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249loading cause activation of mitogen-activated protein
(MAP) kinase pathway and ion channel signaling cascades,
which result in time-varying changes in gene transcription of
matrix proteins, catabolic enzymes, and transcription
factors17e20.
Recent research on the transduction ofmechanical signals
into changes in cell behavior has begun to elucidate the role
of integrin interactions with the extracellular matrix (ECM).
Chondrocytes express a1b1, a2b1, a3b1, a5b1, avb3 and
avb521e23. This expression can change with local microenvi-
ronment, mechanical stimulation, and during osteoarthri-
tis24e26. Integrins play a role in adhesion, cell survival,
regulating matrix metabolism, and in chondrocyte response
to mechanical stimuli (see 27e29 for reviews). b1, a5b1,
avb5 integrins have been shown to mediate chondrocyte ad-
hesion to cut cartilage surfaces21,30. In monolayer studies,
blocking a5b1 integrin interactions led to increased matrix
metalloproteinase-13 (MMP-13) activation and cellular apo-
ptosis23,31. Upregulation of aggrecan mRNA and suppres-
sion of matrix metalloproteinase-3 (MMP-3) mRNA levels
by dynamic stretching of monolayer chondrocytes was
shown to involve a b1 integrin-dependent pathway as well
as stretch-activated ion channels and autocrine/paracrine
stimulation by interleukin-4 (IL-4)32,33. Other studies have
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Fig. 1. Chemical structure for PF001 (previously cited as S24740).
PF001 is a synthetic RGD peptidomimetic that acts as an integ-
rin-binding antagonist with broad speciﬁcity to av and a5 integrins.
250 D. H. Chai et al.: Integrins in chondrocyte mechanotransductionalso identiﬁed a b1 integrin-dependent translocation of pro-
tein kinase C alpha (PKCa) to the cell membrane, increased
association of intracellular receptor for activated C-kinase1
(RACK1) and PKCa with b1 integrin after mechanical stimu-
lation34, and interactions between the integrin associated
protein (CD47/IAP) and a5 integrin35, as possible down-
stream signaling mechanisms. More recently, monolayer
studies demonstrated that blocking with anti-avb5 antibody
could also abolish chondrocyte responses to dynamic
stretching36.
The use of physiologic dynamic compression as a stimu-
lant for cartilage regeneration in tissue engineering has
been demonstrated by several groups10,11,19,37e41 and has
prompted studies of the mechanisms by which cells in tissue
engineered constructs transduce signals under physiological
loading conditions. While some studies suggest a role for ion
channels, especially calcium channels, in regulating sulfated
glycosaminoglycan (sGAG) synthesis in response to dy-
namic compression42,43, studies in 3D culture models have
suggested that the roles are more complicated than that elu-
cidated in monolayer culture models42. Monolayer studies
have provided insights into signaling pathways involved in
chondrocyte mechanotransduction, but the role of cell inter-
actions with newly synthesized and assembled matrix mac-
romolecules in 3D geometries is less well understood.
The goal of this study was to examine the role of integrins
in chondrocyte response to dynamic compression by cells
in 3D agarose gel culture at early times in culture, during ini-
tial evolution of the pericellular matrix, but prior to signiﬁcant
accumulation of further-removed ECM. Chondrocyte cul-
tures in agarose at early times, with little pericellular matrix
present, can respond to dynamic compression with in-
creased sulfate incorporation and sGAG accumula-
tion10,11,39. They also have the added beneﬁt of permitting
the use of multiple methods for perturbing integrinematrix
interactions, including the use of blocking antibodies similar
to those used in monolayer studies, which have diffusive
limitations in native cartilage tissue.MethodsCELL HARVEST AND CULTUREChondrocytes were isolated from the femoral condyle cartilage of 2- to
3-week old bovine calves (Research 87, Marlborough, MA) by sequential
digestion in 0.2% pronase (Protease type XIV, Sigma) and 0.025% Collage-
nase-P (Roche), as described previously44. Cells were seeded in 2% aga-
rose (low melting-temperature, Invitrogen) at concentrations of 15 million
cells/mL using a stainless steel casting frame38,45, in a slab geometry ap-
proximately 1.6 mm thick. 4 mm diameter disks were cored from the slab us-
ing a dermal punch and cultured in 1% ITS-supplemented feed medium (high
glucose Dulbecco’s Modiﬁed Eagles Medium (DMEM), 0.1 mM nonessential
amino acids, 0.4 mM proline, 100 U/mL PSA e penicillin, streptomycin, am-
photeracin, 10 mg/mL ascorbate).INTEGRIN-BLOCKING COMPOUNDSTable I
Molecular weight and relative specificities for PF001, PF002,
PF003. IC50s were measured using specific integrin-transfected
HEK 293 cell-adhesion assays as in Ref. 46. Data obtained from
Pfizer, Inc. PF001 was previously cited as S24746
Mol Wt IC50 (nM)
avb3 avb5 a5b1
PF001 (S247) 569.8 0.40 1.50 64
PF002 388.9 179 1660 1.23
PF003 681.7 0.627 1.38 8940An array of integrin-blocking compounds was used including small-mole-
cule peptidomimetics, function-blocking antibodies, and RGD-containing dis-
integrins. Small-molecule compounds have the advantage of rapid diffusion
times, which allow for more spatial uniformity of treatment. PF001 (previously
referenced as S24746), PF002, PF003 are synthetic peptidomimetics (ob-
tained from Pﬁzer; Fig. 1) of the conserved amino acid motif RGD (argininee
glycineeaspartic acid) and are potent in vitro antagonists (with IC50s on the
order of 1 nM) of ligand interaction with speciﬁc integrins. Their molecular
weights and potencies against selected integrins as measured in integrin-
overexpressing cell-adhesion assays are summarized in Table I. PF001 is
a relatively broad-spectrum blocker while PF002 and PF003 are more spe-
ciﬁc blockers of a5b1 and avb3 integrins, respectively.
To test activity and toxicity of the peptidomimetic compounds, a cell-adhe-
sion assaywas performed using anRGD-conjugated comb copolymer surface
which promotes integrin-mediated adhesion and prevents non-speciﬁcadhesion47e49. Prepared surfaces were obtained50 in which cover slips were
spin-coated with a poly (methyl methacrylate)-graft-poly (ethylene oxide),
PMMA-g-PEO, a comb copolymer with a fraction of PEO side chains function-
alized with maleimide groups using N-(p-maleimidophenyl) isocyanate
(PMPI), and conjugated with a PHSRN-K-GRGDSP peptide (RGD peptideþ
ﬁbronectin synergy site). The RGD-containing peptide was presented in
dispersed and clustered conformations. Further details of polymer synthesis,
peptide synthesis, and surface preparation are described in Kuhlman
et al.48. Cover slips were placed at the bottom of a 24-well plate and held in
place by silicon rings. After isolation, 25,000 chondrocytes were seeded per
well and given 2 h to attach. PF001, PF002, PF003 were then added at con-
centrations of 0, 50, 100, or 200 mM. Cells were cultured for 7 days, with me-
dium changes every other day. Cells were imaged daily using an inverted
microscope to qualitatively observe adhesion and spreading. After 7 days,
cells were stained with ﬂuorescein diacetate (FDA)/ethidium bromide (EtBR)
(live/dead assessment) and imaged using an inverted UV microscope.
Echistatin (Sigma) is a 5.4 kDa disintegrin peptide that non-selectively
blocks the activities of several integrins including avb3, a5b1, and aIIbb3
with IC50s on the order of 10 nM51. Function-blocking antibodies to avb3
(MAB1976, clone LM609), av (MAB1953, clone P3G8), a5 (MAB1956, clone
P1D6), and b1 (MAB1965, clone JB1A) integrins were obtained from Chem-
icon. Cross-reactivity of blocking antibodies MAB1976, MAB1956, and
MAB1965 to bovine integrins have been previously demonstrated52e54 and
are supported by dot-blot analysis (Fig. 1S). Echistatin31 and the blocking an-
tibodies21,23,34,55,56 have been previously used on chondrocytes with no re-
ported cell death. All antibody preps had endotoxin levels below 0.5 EU/mL
(LAL method, Lonza QCL-1000 test kit).MECHANICAL LOADINGOn day of casting, 3e4 chondrocyte-seeded agarose disks maintained in
free-swelling culture were pre-incubated for 18 h in one of the following con-
ditions: (1) untreated control (feed medium), (2) 200 mM PF001, PF002, or
PF003, (3) 5 mg/mL integrin-blocking antibody (each antibody used in sepa-
rate experiments), (4) 1 mM echistatin. Parallel sets of disks from treatment
conditions (1)e(4) were subjected to dynamic compression. Immediately
prior to loading, 5 mCi/mL of 35S-sulfate and 10 mCi/mL of 3H-proline were
added to the medium. Disks were then subjected to a 24-h, 1 Hz continuous,
sinusoidal unconﬁned dynamic compression at 2.5% dynamic strain ampli-
tude (in displacement feedback control) superimposed on a 7% static offset
strain, using a non-porous polysulfone loading chamber and platens in an in-
cubator-housed loading apparatus57. Free-swelling cultures over the same
24-h incubation period served as controls. Throughout the applied compres-
sion, the total harmonic distortion of the resulting continuously measured dy-
namic load signal was <25%. The applied cyclic displacement waveform
and resulting load waveform were similar to that shown in Ref. 37. Upon
completion of loading, plugs were washed 3 20 minutes in phosphate buff-
ered saline (PBS) with 142 mg/mL sodium sulfate and 50 mg/mL L-proline to
remove free radiolabel, and digested in 1 mL Proteinase K (0.1 mg/mL,
Roche) at 60C overnight (w16 h). Experiments were repeated using chon-
drocytes isolated from 1e6 animals (as noted below).
35S-sulfate
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0.0Radiolabel incorporation and sGAG content data were normalized to DNA
content to account for disk-to-disk variations in cell number. Data were fur-
ther normalized to averaged free-swell controls for each animal to account
for baseline animal-to-animal variability. All data are shown as mean 95%
conﬁdence interval (CI). The number of observations varied with treatment,
as detailed in the ﬁgure legends. A ShapiroeWilk test was used to test for
normality of data. One-way and 2-way ANOVA were used to test for the ef-
fect of treatment (mechanical and/or pharmacological) followed by post-hoc
Bonferoni pairwise comparisons to correct for multiple comparisons from
multiple treatments. A P-value< 0.05 was considered signiﬁcant. Statistical
analysis was performed using Systat 12 software (Richmond, CA).Fig. 2. Biosynthetic response of chondrocytes in agarose culture to
24 h of dynamic compression (1.0 Hz, 2.5% amplitude) in the pres-Results
ence of small-molecule integrin blockers PF001, PF002, PF003
(200 mM). Data were normalized by the averaged untreated free-ACTIVITY AND TOXICITY OF PF001, PF002, PF003swell control for each animal. Data shown as mean  95% CI,
n¼ 6e19 disks from 2e6 animals (PF001 n ¼ 6, PF002 n¼ 6,
PF003 n¼ 19). Sulfate incorporation as measured by radiolabel in-
corporation. GAG accumulation as measured by DMMB dye-
binding assay. ***P< 0.0005 relative to free-swell, þP< 0.0005
relative to untreated controls.RGD-conjugated comb copolymer surfaces that can pro-
mote binding by the avb3 or a5b1 integrins were used to
conﬁrm activity of PF001, PF002, and PF003 on chondro-
cytes. By day 6 in culture, untreated cells seeded onto
RGD-conjugated surfaces showed a spread morphology,
while cells treated with 100 mM PF001, PF002, or PF003 re-
mained rounded on the RGD-conjugated surfaces through-
out the 7-day treatment (Supplementary Fig. 2S). Treatment
with 1 mM echistatin served as an assay control. At concen-
trations up to 200 mM of each compound over 7 days, there
was no qualitative increase in ethidium bromide-stained
cells (approximately 10%) (Fig. 2S) compared to untreated
controls or quantitative changes in DNA content (Fig. 3S),
suggesting no adverse effects on cell viability.EFFECTS OF SMALL-MOLECULE BLOCKERS ON GAG
BIOSYNTHESIS AND ACCUMULATION WITH DYNAMIC
COMPRESSION OF AGAROSE GEL CULTURESTo test the role of integrineECM interactions in chondro-
cyte biosynthetic response to dynamic compression, aga-
rose cultures were incubated with small-molecule
peptidomimetics of the RGD-binding sequence recognized
by integrins such as avb3 and a5b1 to block these interac-
tions and subjected to a 24-h continuous, unconﬁned dy-
namic compression. At the end of the loading period,
untreated free-swelling cultures incorporated an average
of 192 pmol sulfate/mg DNA/h and accumulated 7.38 mg
GAG/mg DNA. Treatment with PF001, PF002, or PF003
did not alter DNA content (Supplementary Fig. 3S). DNA
content was used to normalize data for all subsequent anal-
yses. In free-swelling controls, PF001 and PF002 did not
signiﬁcantly change sulfate incorporation or sulfated GAG
content, while PF003 (200 mM) resulted in a 27% decrease
in sulfate incorporation (P< 0.0005 compared to untreated
control using post-hoc Bonferoni pairwise comparison)
and 17% decrease GAG content (P< 0.0005 vs untreated
control) (Fig. 2). Free-swell levels for sulfate incorporation
and GAG content under all treatment conditions can be
found in Supplementary Materials (Fig. 5S).
Consistent with previous studies10,11,39, low amplitude
(<10% strain amplitude) dynamic compression at 1 Hz fre-
quency increased sulfate incorporation rates by approxi-
mately 25% (to 243 pmol sulfate/mg DNA/h, P< 0.0005 vs
free-swell control) after 24 h of compression in untreatedagarose gel plugs (Fig. 2). GAG loss to the medium was
minimal: <10% of the total GAG content (i.e., agarose
disk plus medium combined) or approximately 0.7 mg
GAG/mg DNA, was lost to the medium over 24 h in free-
swell culture. While GAG loss to medium increased by
w75% to 1.2 mg GAG/mg DNA with dynamic compression,
possibly due to increased transport, enhanced synthesis
caused a net increase in GAG accumulation within the disks
after 24 h of dynamic compression by w14% (to 8.51 mg
GAG/mg DNA, P< 0.0005 vs free-swell control) (Fig. 2).
Since the experiment was conducted during early times in
culture and GAG loss was minimal, the majority of the
GAG content was newly synthesized and GAG accumula-
tion mirrored sulfate incorporation trends.
PF001-treated samples responded to dynamic compres-
sion with similar increases in sulfate incorporation (27%,
P< 0.0005 compared to treated free-swell control in post-
hoc Bonferoni comparison) and GAG accumulation (15%,
P¼ 0.089 vs treated free-swell control, P¼ 0.017 uncor-
rected) (Fig. 2). PF002-treated samples responded to dy-
namic compression with slight increases in sulfate
incorporation (12%, P¼ 0.16 vs treated free-swell control,
P¼ 0.03 uncorrected) and GAG accumulation (6%). In con-
trast, PF003-treated samples showed no stimulation of sul-
fate incorporation or GAG accumulation with dynamic
compression (Fig. 2). None of the treatments (PF001,
PF002, or PF003) affected GAG loss to the medium. Taken
together, markers of PG synthesis (sulfate incorporation
and GAG content) were responsive to dynamic compres-
sion and sensitive to the integrin blocker PF003, the most
selective inhibitor of avb3 function. A dose response exper-
iment up to the efﬁcacious concentration of 200 mM with
PF003 was then conducted: PG synthesis response to dy-
namic compression was measured at 0, 100, 150, 200 mM
PF003. Free-swelling disks showed a graded decrease in
sulfate incorporation and GAG accumulation with increas-
ing concentrations of PF003 [Fig. 4S(A, B)]. Stimulation of
PG synthesis (sulfate incorporation and GAG accumulation)
252 D. H. Chai et al.: Integrins in chondrocyte mechanotransductionby dynamic compression relative to free-swell also varied
with increasing concentrations of PF003, with a slight
(10%, P¼ 0.8 compared to treated free-swell in Bonferoni
post-hoc pairwise comparison, P¼ 0.15 uncorrected) in-
crease in sulfate incorporation and GAG accumulation at
100 mM, and no stimulation by 150 mM PF003 (Fig. 4S).BROAD-SPECTRUM BLOCKERS PF001 AND ECHISTATIN
SHOWED LITTLE EFFECT ON RESPONSE TO DYNAMIC
COMPRESSIONEchistatin is a disintegrin containing the RGD-motif that has
broad speciﬁcity to integrins51. In free-swelling controls, echis-
tatin decreased sulfate incorporation by 43% (P< 0.0005
compared to untreated control in Bonferoni post-hoc pairwise
comparison) and GAG content by 21% (P< 0.0005 vs un-
treated control) [Fig. 3(A)], and increasedGAG loss tomedium
by77%. Incontrast,PF001hadnoeffect on radiolabel incorpo-
ration or GAG accumulation in free-swelling conditions. With
PF001 treatment, dynamic compression increased sulfate in-
corporation byw20% (P< 0.0005 compared to treated free-
swell) and slightly increased GAG content (P¼ 0.071 vs
treated free-swell, P¼ 0.02 uncorrected). In contrast, with
echistatin treatment, dynamic compression increased sulfate
incorporation in treated samples by w20% (P¼ 0.125,
P¼ 0.032 uncorrected), and dynamic compression did not
stimulate GAG accumulation [Fig. 3(B)]. This may be due to
GAG loss to medium, not seen in PF001-treated samples,
since the total GAG content (agarose disk þ medium) in-
creased by &sim;9% after 24 h dynamic compression in the
presence of echistatin.DIFFERENTIAL EFFECTS OF INTEGRIN BLOCKERS IN
FREE-SWELLING CULTURETo further test the hypothesis that blocking speciﬁc integ-
rineECM interactions can disrupt chondrocyte response to
dynamic compression, a series of blocking antibodies
were used in parallel experiments. Antibodies are larger inll
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Fig. 3. Effects of broad-spectrum integrin antagonists PF001 and echista
lation of agarose cultures (B). Data shown as mean 95% CI. (A) Sulfat
controls. n¼ 6e51 samples from 2e11 animals (control n¼ 51, PF001 n¼
PG synthesis as indicated by sulfate incorporation and GAG content w
n¼ 6e13 samples from 2e4 animals (control n¼ 13, PF001 n¼ 6, ec
free-swesize (w150 kDa), but in agarose culture at early times be-
fore much accumulation of ECM, antibodies can still diffuse
in relatively easily61,62. avb3 blocker PF003 decreased sul-
fate incorporation by approximately 30% (P< 0.0005 com-
pared to untreated control by Bonferoni pairwise
comparisons) and GAG accumulation by 18% (P< 0.0005
vs untreated control) in free-swelling culture [Fig. 4(A)].
avb3 blocking antibody clone LM609 showed a slight but
non-signiﬁcant decrease in sulfate incorporation at 5 mg/mL
[Fig. 4(A)]. av blocking antibodies showed no effects on
sulfate incorporation, GAG accumulation, or GAG loss in
free-swelling culture [Fig. 4(A)]. In contrast, a5b1 blocker
PF002 showed a slight increase in sulfate incorporation
(9%) and GAG accumulation (6%) under free-swelling con-
ditions (Fig. 5), and blocking antibodies to b1 (5 mg/mL,
10 mg/mL) integrins increased sulfate incorporation rates,
and GAG accumulation by 20e40% (P< 0.0005, vs un-
treated control) [Fig. 5(A)]. None of the blocking antibodies
had signiﬁcant affects on GAG loss to the medium.aVb3 AND b1 BLOCKING ANTIBODIES, NOT PF002 OR a5
BLOCKING ANTIBODIES, ABOLISHED PG SYNTHESIS
RESPONSE TO COMPRESSIONIn untreated samples, dynamic compression increased
sulfate incorporation rates by approximately 20%
(P< 0.0005 compared to free-swell control by Bonferoni
post-hoc comparison) and GAG accumulation by 14%
(P< 0.0005 vs free-swell control). Treatment with PF003,
avb3 blocking antibodies, and av blocking antibodies abro-
gated this response to dynamic compression (P< 0.0005
by ANOVA) [Fig. 4(B)]. In separate experiments with
PF002 and a5 blocking antibody-treated samples, dynamic
compression resulted in a 12e15% increase in sulfate in-
corporation (P¼ 0.079, 0.023, respectively vs treated free-
swell controls, P¼ 0.011, 0.006 uncorrected), while GAG
accumulation increased by only 5e10% [Fig. 5(B)]. b1
blocking antibody-treated samples showed no stimulation
of sulfate incorporation or GAG accumulation by dynamic0
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Fig. 4. Effects of blocking avb3 integrins on biosynthetic behavior in
free-swelling culture and in response to dynamic compression.
Data shown as mean  95% CI. (A) Sulfate incorporation and
GAG content in free-swelling agarose cultures relative to untreated
controls. n¼ 3e51 samples from 1e11 animals (control n¼ 51,
PF003 n ¼ 29, avb3 n ¼ 16, 5 mg/mL av n ¼ 12, 10 mg/mL av
n¼ 3), ***P< 0.0005 relative to untreated control. (B) PG synthesis
(sulfate incorporation and GAG accumulation) after 24 h of dynamic
compression relative to respective treated free-swell controls.
n ¼ 3e19 samples from 1e6 animals (control n ¼ 19, PF003
n ¼ 19, avb3 n ¼ 3, 5 mg/mL av n ¼ 9, 10 mg/mL av n ¼ 3),
***P< 0.0005 relative to 1 (no change compared to free-swell).
l
ort
noc
d
et
aert
n
u
ot
evit
al
er
es
n
ops
e
R
untreated 
control
PF002 5 g/mL
α5
5 g/mL
β β1
10 g/mL
1
***
***
35S-sulfate
GAG
Free-swell Response
1.8
A
B
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
***
***
0
0.2
0.4
0.6
0.8
1
1.2
1.4
untreated 
control
PF002 5 g/mL
5
5 g/mL
1
10 g/mL
1
***
** *
35S-sulfate
GAG
Response to Dynamic Compression
μ μ μ
μ μ μ
α β β
ll
e
ws
eerf
ot
evit
al
er
n
oiss
erp
m
oc
ci
ma
nyd
ot
es
n
ops
e
R
Fig. 5. Effects of blocking a5b1 integrins on agarose cultures in
free-swelling culture and in response to dynamic compression.
Data shown as mean  95% CI. (A) Sulfate incorporation and
GAG content in free-swelling agarose cultures relative to untreated
controls. n¼ 3e51 samples from 1e11 animals (control n¼ 51,
PF002 n ¼ 6, a5 n ¼ 6, 5 mg/mL b1 n ¼ 6, 10 mg/mL b1 n ¼ 3),
***P< 0.0005 relative to untreated controls. (B) PG synthesis (sul-
fate incorporation and GAG content) response after 24 h of dy-
namic compression relative to respective treated free-swell
controls. n ¼ 3e12 samples from 1e4 animals (control n¼ 12,
PF002 n ¼ 6, a5 n ¼ 6, 5 mg/mL b1 n ¼ 6, 10 mg/mL b1 n ¼ 3).
***P< 0.0005, **P¼ 0.001, *P¼ 0.023 relative to 1 (no change
compared to free-swell).
253Osteoarthritis and Cartilage Vol. 18, No. 2compression [Fig. 5(B)]. None of these effects described
were due to changes in GAG loss to medium. While
blockers of avb3 and b1 integrins both appear to abrogate
the response to dynamic compression, they appear to be
acting through distinct pathways considering their opposing
effects in free-swelling culture.Discussion
Dynamic compression and other mechanical stimuli have
been increasingly used in tissue engineering to promote de-
velopment of cartilage constructs through increasing ECM
content andmechanical properties37,38, and the use of imma-
ture chondrocytes in tissue engineering and cartilage repair
has been shown to be an effective cell source for tissue engi-
neering, with greater activity than adult chondrocytes63e65.
Even at early times in culture, when little pericellular matrix
is present, chondrocyte cultures in agarose can respond to
dynamic compression with increased sulfate incorporation
and sGAG accumulation10,11,39. This response to 24 h of
continuous dynamic compression increased with number ofdays in free-swell culture10. In long-term studies of the effects
of dynamic loading, the presence of a pre-elaborated pericel-
lular matrix (either by seeding chondrons initially or culturing
for 2 weeks prior to loading) did not alter the stimulatory
effects of extended dynamic loading, which increased with
loading duration37. This suggests that interactions between
the cell and its surroundingmatrix developed during dynamic
compression may play a greater role than pre-existing inter-
actions. The goal of this study was to examine the role of
integrineECM interactions in the response of chondrocytes
to dynamic compression at early times in culture using
a 3D agarose culture of immature bovine chondrocytes as
a model system. An added beneﬁt of studying such interac-
tions at early times is the ability to compare multiple integrin
blockers, including antibodies,without the complicating issue
of diffusion and penetration of antibodies into a dense tissue
matrix. The results of this study suggest that multiple integ-
rins (b1, avb3) appear to play a role in mechanotransduction
and the chondrocyte’s ability to sense its local microenviron-
ment; however these integrins appear to play opposing or
complementary roles.
254 D. H. Chai et al.: Integrins in chondrocyte mechanotransductionIn thepresent study, blockingb1 integrin functionwith block-
ing antibodies, or blocking avb3 integrins with either small-
molecule antagonists or blocking antibodies, abolished PG
stimulation by dynamic compression (as measured by sulfate
incorporationor sGAGaccumulation).While the concentration
of the small-molecule antagonists used in these functional as-
saysweremuch higher than the IC50s reported in Table I, pre-
vious studies have conﬁrmed the observation that higher
concentrations are necessary to see functional response, es-
pecially in 3D culture models66. Our results using blocking an-
tibodies support the speciﬁcity of these small-molecules as
well. As previously shown10,11,39, 24 h continuous unconﬁned
dynamic compression stimulatedPGsynthesis at days 1e2 in
culture. Measurable amounts of sGAG were accumulated in
constructs by the end of culture. Previous studies have also
shown that a pericellular matrix begins developing within 4 h
after isolation67 and can be visualized at the cell surface on
day 2 in agarose culture68. The b1 integrin subunit can associ-
ate with a large number of differentially expressed alpha sub-
units to form integrins with distinct ligand binding and cell
signaling characteristics. Echistatin and the RGD peptidomi-
metics used in this studyareexpected to inhibit only the subset
of b1-containing integrins that interact with their ligands via the
RGD sequence. avb3 and a5b1 are bothRGD-recognizing in-
tegrins.While themain binding partners for avb3 and a5b1 are
vitronectin and ﬁbronectin, respectively, avb3 has also been
shown to bind to ﬁbronectin, ﬁbrinogen, osteopontin, and col-
lagen69. Blocking a5b1 speciﬁcally using the RGD peptidomi-
metic PF002 or a5 blocking antibodies may partially decrease
PG stimulation by dynamic compression, but this effect was
not signiﬁcant. Other potentialb1 integrins include collagen re-
ceptors a1b1 and a2b1, as well as a3b1 and a10b1.
While blocking both avb3 and b1 integrins prevented stim-
ulation of PG synthesis by dynamic compression, these re-
sults appeared to be acting through independent
mechanisms. In this study, blocking b1 integrins in free-swell-
ing culture with blocking antibodies resulted in a signiﬁcant
upregulation of sulfate incorporation, while blocking avb3 in-
tegrins with small-molecule compounds resulted in a down
regulation. Blocking avb3 integrins with antibodies resulted
in no detectable change in basal sulfate incorporation. Previ-
ous studies have suggested that avb3 and a5b1 havemodu-
lating roles in articular chondrocytes56. In those studies,
treatment with anti-a5b1 antibody JBS5 induced a pro-in-
ﬂammatory response (upregulation of NO, prostaglandin
E2 (PGE2), IL-6, IL-8, and IL-1b) in both normal and osteoar-
thritic cartilage as well as bovine articular chondrocytes,
while treatment with avb3 blocking antibody LM609 de-
creased these pro-inﬂammatory signals and could regulate
the a5b1 response in a dominant-negative fashion56. Other
studies demonstrated similar responses when blocking with
anti-a5b1 antibodies or treating with ﬁbronectin fragments23.
In addition, studies have shown that blocking a1b1 and a2b1
with blocking antibodies can stimulate MMP-13 production
through the MAP kinase pathway similar to treatment with
a5b1 blocking antibodies or ﬁbronectin fragments23,70,
although their roles in mechanotransduction had not previ-
ously been investigated to our knowledge. These studies
demonstrate that the use of blocking antibodies can induce
cellular responses by disrupting integrin signaling or causing
abnormal signaling. While the stimulation of PG synthesis by
blocking b1 integrins in agarose culture might appear to be in
contradiction to these previous studies, it is possible that the
stimulation observed, here, is part of increased turnover that
has been described previously with hyaluronan (HA) oligo-
saccharide treatment of cartilage71. In addition, only blockers
of b1 integrins that induced an increase in biosynthesis infree-swelling controls resulted in abolishment of the
response to dynamic compression, and the effects of block-
ing antibodies were distinct from that of small-molecule an-
tagonists, which likely block integrin interactions through
different mechanisms. Taken together, these studies sug-
gest that blocking b1 integrins with blocking antibodies may
decrease response to dynamic compression through a pro-
inﬂammatory pathway or an analogous pathway resulting
from abnormal integrin signaling.
Consistent with previous studies, we observed that treat-
ment with different types of avb3 blockers can result in dis-
tinctly different free-swelling responses56. However, all
speciﬁc blockers of avb3 integrins affected stimulation of
PG synthesis by dynamic compression. Thus, blocking
avb3 appears to be inhibiting a signaling response directly re-
sulting from dynamic compression, independent of effects in
free-swelling culture. Finally, our observation that treatment
with relatively broad-spectrum blockers (PF001 and echista-
tin) that target RGD-binding integrins, andwhich bind to a5b1
andavb3with similar afﬁnities, did not affect stimulation ofPG
synthesis by dynamic compression, suggests a modulatory
role for a5b1 and avb3 as seen in previous studies56.
It is important to note that previous studies of the role of
a5b1 integrins in chondrocyte mechanotransduction fo-
cused on chondrocyte monolayer cultures23,31e35. The
present study utilizes 3D gel culture, and the results in 3D
suggest a more complex view in which multiple integrins
may be playing a role in regulating chondrocyte response
to compression within the gel construct. This hypothesis is
consistent with research on the role of ion channel signal-
ing, where more complex interactions were observed in
3D compared to 2D culture43. A variety of mechanical sig-
nals are present during physiological (3D) dynamic com-
pression (e.g., ﬂuid ﬂow, pressure gradients, streaming
potentials, deformation)4e6. Even at early times in culture,
the presence of PGs would contribute to streaming poten-
tials and osmotic gradients, while cell and pericellular matrix
deformation72 and ﬂuid ﬂow may affect receptoreECM in-
teractions. With the multitude of signals, it is conceivable
that individual ligandesurface receptor interactions may
be sensing different mechanical signals, mechanisms for
which are beginning to be elucidated73. Finally, further stud-
ies on downstream signaling events may shed light on how
upstream mechanical signals may interact, and allow for
better understanding as to how mechanical stimulation
may be utilized to optimize ECM development in cartilage
tissue engineering applications.Conﬂict of interest
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